You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API primaquine phosphate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing primaquine phosphate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Sanofi-Aventis US LLC PRIMAQUINE PHOSPHATE primaquine phosphate 0024-1596 CARNAUBA WAX
Sanofi-Aventis US LLC PRIMAQUINE PHOSPHATE primaquine phosphate 0024-1596 CELLULOSE, MICROCRYSTALLINE
Sanofi-Aventis US LLC PRIMAQUINE PHOSPHATE primaquine phosphate 0024-1596 FERRIC OXIDE RED
Sanofi-Aventis US LLC PRIMAQUINE PHOSPHATE primaquine phosphate 0024-1596 HYPROMELLOSE 2910
Sanofi-Aventis US LLC PRIMAQUINE PHOSPHATE primaquine phosphate 0024-1596 LACTOSE
Sanofi-Aventis US LLC PRIMAQUINE PHOSPHATE primaquine phosphate 0024-1596 MAGNESIUM STEARATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing primaquine phosphate

Company Ingredient NDC Excipient
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671 CELLULOSE, MICROCRYSTALLINE
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671 FD&C BLUE NO. 2
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671 FD&C RED NO. 40
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671 HYPROMELLOSES
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671 LACTOSE MONOHYDRATE
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for primaquine phosphate

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

primaquine phosphate drug variants not containing FD&C YELLOW NO. 6

Company Ingredient NDC
Sanofi-Aventis US LLC primaquine phosphate 0024-1596
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671
PD-Rx Pharmaceuticals Inc primaquine phosphate 43063-225
PD-Rx Pharmaceuticals Inc primaquine phosphate 43063-721
Golden State Medical Supply Inc primaquine phosphate 60429-035
Bayshore Pharmaceuticals LLC primaquine phosphate 76385-102
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: FERRIC OXIDE RED

primaquine phosphate drug variants not containing FERRIC OXIDE RED

Company Ingredient NDC
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671
AvKARE primaquine phosphate 42291-510
PD-Rx Pharmaceuticals Inc primaquine phosphate 43063-721
Ingenus Pharmaceuticals LLC primaquine phosphate 50742-191
Golden State Medical Supply Inc primaquine phosphate 60429-035
Bayshore Pharmaceuticals LLC primaquine phosphate 76385-102
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

primaquine phosphate drug variants containing LACTOSE MONOHYDRATE

Company Ingredient NDC
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671
AvKARE primaquine phosphate 42291-510
PD-Rx Pharmaceuticals Inc primaquine phosphate 43063-721
Ingenus Pharmaceuticals LLC primaquine phosphate 50742-191
Golden State Medical Supply Inc primaquine phosphate 60429-035
Bayshore Pharmaceuticals LLC primaquine phosphate 76385-102
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

primaquine phosphate drug variants not containing POLYSORBATE 80

Company Ingredient NDC
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671
AvKARE primaquine phosphate 42291-510
PD-Rx Pharmaceuticals Inc primaquine phosphate 43063-721
Ingenus Pharmaceuticals LLC primaquine phosphate 50742-191
Golden State Medical Supply Inc primaquine phosphate 60429-035
Bayshore Pharmaceuticals LLC primaquine phosphate 76385-102
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: STARCH, CORN

primaquine phosphate drug variants containing STARCH, CORN

Company Ingredient NDC
Sanofi-Aventis US LLC primaquine phosphate 0024-1596
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671
PD-Rx Pharmaceuticals Inc primaquine phosphate 43063-225
PD-Rx Pharmaceuticals Inc primaquine phosphate 43063-721
Golden State Medical Supply Inc primaquine phosphate 60429-035
Bayshore Pharmaceuticals LLC primaquine phosphate 76385-102
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: STARCH, PREGELATINIZED CORN

primaquine phosphate drug variants not containing STARCH, PREGELATINIZED CORN

Company Ingredient NDC
Sanofi-Aventis US LLC primaquine phosphate 0024-1596
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671
PD-Rx Pharmaceuticals Inc primaquine phosphate 43063-225
PD-Rx Pharmaceuticals Inc primaquine phosphate 43063-721
Golden State Medical Supply Inc primaquine phosphate 60429-035
Bayshore Pharmaceuticals LLC primaquine phosphate 76385-102
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

primaquine phosphate drug variants not containing TRIACETIN

Company Ingredient NDC
Sanofi-Aventis US LLC primaquine phosphate 0024-1596
Aidarex Pharmaceuticals LLC primaquine phosphate 33261-671
PD-Rx Pharmaceuticals Inc primaquine phosphate 43063-225
PD-Rx Pharmaceuticals Inc primaquine phosphate 43063-721
Golden State Medical Supply Inc primaquine phosphate 60429-035
Bayshore Pharmaceuticals LLC primaquine phosphate 76385-102
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group